Ngā hua rapu - Rebecca Dielschneider
- E whakaatu ana i te 1 - 5 hua o te 5
-
1
Lysosomes as Oxidative Targets for Cancer Therapy mā Rebecca Dielschneider, Elizabeth S. Henson, Spencer B. Gibson
I whakaputaina 2017Revisão -
2
-
3
Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism mā Rebecca Dielschneider, Hannah Eisenstat, Si Mi, Jonathan M. Curtis, Wenyan Xiao, James B. Johnston, Spencer B. Gibson
I whakaputaina 2016Artigo -
4
Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells mā Shumei Ma, Rebecca Dielschneider, Elizabeth S. Henson, Wenyan Xiao, Tricia R. Choquette, Anna R. Blankstein, Yongqiang Chen, Spencer B. Gibson
I whakaputaina 2017Artigo -
5
Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation mā Shashi Gujar, Rebecca Dielschneider, Derek R. Clements, Erin Helson, Maya Shmulevitz, Paola Marcato, Da Pan, Lu-Zhe Pan, Dae‐Gyun Ahn, Abdulaziz Alawadhi, Patrick W.K. Lee
I whakaputaina 2013Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Cancer
Cancer research
Apoptosis
Biochemistry
Cancer cell
Cell biology
Genetics
Immunology
Programmed cell death
Autophagy
Chemistry
Enzyme
Immune system
Internal medicine
Lysosome
Medicine
Oncolytic virus
Reactive oxygen species
Breast cancer
CD8
Chronic lymphocytic leukemia
Context (archaeology)
Deferoxamine
FOXP3
Gemcitabine
Immunosuppression
Immunotherapy
Lapatinib
Leukemia